OptimizeRx CorpNASDAQ:OPRX
- LAST PRICE5.4500
- TODAY'S CHANGE (%)0.1200 (2.2514%)
- Bid / Lots4.3400/ 1
- Ask / Lots5.7500/ 1
- Open / Previous Close5.3700 / 5.3300
- Day Range
- 52 Week Range
- Volume96,484
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OPRX |
|---|---|---|
| 09:32 ET | 738 | 5.37 |
| 09:33 ET | 1470 | 5.48 |
| 09:35 ET | 299 | 5.45 |
| 09:39 ET | 114 | 5.335 |
| 09:55 ET | 100 | 5.4458 |
| 09:57 ET | 800 | 5.4 |
| 10:04 ET | 100 | 5.4 |
| 10:06 ET | 200 | 5.38 |
| 10:08 ET | 328 | 5.3919 |
| 10:09 ET | 500 | 5.38 |
| 10:20 ET | 100 | 5.29 |
| 10:22 ET | 700 | 5.256 |
| 10:24 ET | 850 | 5.27 |
| 10:26 ET | 200 | 5.265 |
| 10:27 ET | 300 | 5.27 |
| 10:29 ET | 1500 | 5.4 |
| 10:31 ET | 226 | 5.36 |
| 10:33 ET | 300 | 5.36 |
| 10:38 ET | 794 | 5.36 |
| 10:40 ET | 177 | 5.36 |
| 10:54 ET | 741 | 5.335 |
| 10:56 ET | 100 | 5.35 |
| 10:58 ET | 1707 | 5.3499 |
| 11:00 ET | 200 | 5.32 |
| 11:02 ET | 200 | 5.29 |
| 11:03 ET | 100 | 5.32 |
| 11:05 ET | 324 | 5.3357 |
| 11:09 ET | 100 | 5.32 |
| 11:16 ET | 1400 | 5.325 |
| 11:21 ET | 1667 | 5.35 |
| 11:23 ET | 400 | 5.38 |
| 11:32 ET | 2513 | 5.4 |
| 11:38 ET | 659 | 5.395 |
| 11:41 ET | 180 | 5.395 |
| 11:48 ET | 170 | 5.39 |
| 11:52 ET | 1330 | 5.395 |
| 11:54 ET | 300 | 5.39 |
| 11:56 ET | 2410 | 5.41 |
| 11:57 ET | 5250 | 5.445 |
| 12:01 ET | 100 | 5.435 |
| 12:08 ET | 655 | 5.425 |
| 12:12 ET | 1000 | 5.4 |
| 12:15 ET | 200 | 5.4 |
| 12:19 ET | 300 | 5.4 |
| 12:24 ET | 100 | 5.405 |
| 12:26 ET | 712 | 5.435 |
| 12:28 ET | 1300 | 5.46 |
| 12:32 ET | 1509 | 5.44 |
| 12:44 ET | 2190 | 5.44 |
| 12:46 ET | 5949 | 5.475 |
| 12:50 ET | 2120 | 5.485 |
| 12:51 ET | 1756 | 5.47 |
| 12:55 ET | 1100 | 5.43 |
| 12:57 ET | 2710 | 5.41 |
| 01:00 ET | 16900 | 5.45 |
Nov 18, 2024
OptimizeRx to Participate in Upcoming Investor Conferences, from 7:30AM ET on Monday Nov 18, 2024 by Dow Jones
7:30AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 14, 2024
DJ OptimizeRx Shares Slump After 3Q Results Miss Estimates, Cuts Outlook, from 12:11PM ET on Thursday Nov 14, 2024 by Dow Jones
12:11PM ET on Thursday Nov 14, 2024 by Dow JonesDJ OptimizeRx Is Maintained at Outperform by RBC Capital, from 12:06PM ET on Thursday Nov 14, 2024 by Dow Jones
12:06PM ET on Thursday Nov 14, 2024 by Dow JonesDJ OptimizeRx Price Target Cut to $16.00/Share From $20.00 by Roth MKM, from 11:00AM ET on Thursday Nov 14, 2024 by Dow Jones
11:00AM ET on Thursday Nov 14, 2024 by Dow JonesDJ OptimizeRx Is Maintained at Buy by Stifel, from 9:41AM ET on Thursday Nov 14, 2024 by Dow Jones
9:41AM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
OptimizeRx Corp | 98.2M | -4.1x | --- |
Gorilla Technology Group Inc | 55.9M | 2.1x | --- |
Antelope Enterprise Holdings Ltd | 3.0M | -0.1x | --- |
CSP Inc | 154.5M | 58.4x | --- |
Gaia Inc | 142.9M | -21.0x | --- |
CuriosityStream Inc | 101.5M | -6.6x | --- |
Company Information
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Contact Information
- Headquarters
- 260 CHARLES STREET, SUITE 302WALTHAM, MA, United States 02453
- Phone
- 248-651-6558
- Fax
- 248-453-5529
Executives
- Independent Chairperson of the Board
- Lynn Vos
- President
- Stephen Silvestro
- Chief Executive Officer, Director
- William Febbo
- Chief Financial Officer, Chief Operating Officer
- Edward Stelmakh
- Chief Compliance Officer, General Counsel
- Marion Odence-Ford
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $98.2M |
|---|---|
Revenue (TTM) | $88.2M |
Shares Outstanding | 18.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.34 |
EPS | $-1.33 |
Book Value | $6.97 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32.03% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
